United States - English - NLM (National Library of Medicine)

hikma pharmacuticals usa usa inc. - clotrimazole (unii: g07gz97h65) (clotrimazole - unii:g07gz97h65) - clotrimazole 10 mg - clotrimazole is indicated for the local treatment of oropharyngeal candidiasis. the diagnosis should be confirmed by a koh smear and/or culture prior to treatment. clotrimazole is also indicated prophylactically to reduce the incidence of oropharyngeal candidiasis in patients immunocompromised by conditions that include chemotherapy, radiotherapy, or steroid therapy utilized in the treatment of leukemia, solid tumors, or renal transplantation. there are no data from adequate and well-controlled trials to establish the safety and efficacy of this product for prophylactic use in patients immunocompromised by etiologies other than those listed in the previous sentence. (see dosage and administration.) clotrimazole is contraindicated in patients who are hypersensitive to any of its components. no data available.

New Zealand - English - Medsafe (Medicines Safety Authority)

bayer new zealand limited - clotrimazole 2%{relative}; clotrimazole 2%{relative} - vaginal cream - 2 % - active: clotrimazole 2%{relative} excipient: benzyl alcohol cetostearyl alcohol cetyl palmitate octyldodecanol polysorbate 60 purified water sorbitan stearate active: clotrimazole 2%{relative} excipient: benzyl alcohol cetostearyl alcohol cetyl palmitate octyldodecanol polysorbate 60 purified water sorbitan stearate - canesten clotrimazole thrush treatment once, 3 day and 6 day creams are indicated for the topical treatment of vulvovaginal candidiasis. canesten clotrimazole cream may also be used in conjunction with canesten clotrimazole vaginal pessaries in the management of candida vulvovaginitis or infection of the peri-anal area, while application of the cream to the glans penis of the partner may help prevent re-infection of the female.

New Zealand - English - Medsafe (Medicines Safety Authority)

bayer new zealand limited - clotrimazole 1%{relative}; clotrimazole 1%{relative} - vaginal cream - 1 % - active: clotrimazole 1%{relative} excipient: benzyl alcohol cetostearyl alcohol cetyl palmitate octyldodecanol polysorbate 60 purified water sorbitan stearate active: clotrimazole 1%{relative} excipient: benzyl alcohol cetostearyl alcohol cetyl palmitate octyldodecanol polysorbate 60 purified water sorbitan stearate - canesten clotrimazole thrush treatment once, 3 day and 6 day creams are indicated for the topical treatment of vulvovaginal candidiasis. canesten clotrimazole cream may also be used in conjunction with canesten clotrimazole vaginal pessaries in the management of candida vulvovaginitis or infection of the peri-anal area, while application of the cream to the glans penis of the partner may help prevent re-infection of the female.

United States - English - NLM (National Library of Medicine)

roxane - clotrimazole (unii: g07gz97h65) (clotrimazole - unii:g07gz97h65) - lozenge - clotrimazole troches (clotrimazole lozenges) are indicated for the local treatment of oropharyngeal candidiasis. the diagnosis should be confirmed by a koh smear and/or culture prior to treatment. clotrimazole troches (clotrimazole lozenges) are also indicated prophylactically to reduce the incidence of oropharyngeal candidiasis in patients immunocompromised by conditions that include chemotherapy, radiotherapy, or steroid therapy utilized in the treatment of leukemia, solid tumors, or renal transplantation. there are no data from adequate and well-controlled trials to establish the safety and efficacy of this product for prophylactic use in patients immunocompromised by etiologies other than those listed in the previous sentence. (see dosage and administration.) clotrimazole troches (clotrimazole lozenges) are contraindicated in patients who are hypersensitive to any of its components. no data available.

United States - English - NLM (National Library of Medicine)

trifecta pharmaceuticals usa llc - clotrimazole (unii: g07gz97h65) (clotrimazole - unii:g07gz97h65) - clotrimazole 1 g in 100 g - antifungal cream cures athlete’s foot (tinea pedis), jock itch (tinea cruris), ringworm (tinea corporis). relieves the itching, irritation, redness, scaling and discomfort which can accompany these conditions. do not use on children under 2 years of age unless direcgted by a doctor - irritaion occurs - there is no improvement within 4 weeks (for athlete's foot or ringworm) or within 2 weeks (for jock itch).

United States - English - NLM (National Library of Medicine)

novitium pharma llc - clotrimazole (unii: g07gz97h65) (clotrimazole - unii:g07gz97h65) - prescription clotrimazole topical solution product is indicated for the topical treatment of candidiasis due to candida albicans and tinea versicolor due to malassezia furfur .  this formulation is also available as a nonprescription product which is indicated for the topical treatment of the following dermal infections: tinea pedis, tinea cruris, and tinea corporis due to trichophyton rubrum , trichophyton mentagrophytes, epidermophyton fluoccosum, and microsporum canis .  topical antifungal agents are contraindicated in those patients with a history of hypersensitivity to any of the components of the preparation.

United States - English - NLM (National Library of Medicine)

nucare pharamceuticals,inc. - clotrimazole (unii: g07gz97h65) (clotrimazole - unii:g07gz97h65), betamethasone dipropionate (unii: 826y60901u) (betamethasone - unii:9842x06q6m) - clotrimazole 10 mg in 1 g - clotrimazole and betamethasone dipropionate cream is a combination of an azole antifungal and corticosteroid and is indicated for the topical treatment of symptomatic inflammatory tinea pedis, tinea cruris, and tinea corporis due to epidermophyton floccosum, trichophyton mentagrophytes, and trichophyton rubrum in patients 17 years and older. none. teratogenic effects pregnancy category c there are no adequate and well-controlled studies with clotrimazole and betamethasone dipropionate cream in pregnant women. therefore, clotrimazole and betamethasone dipropionate cream should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. there have been no teratogenic studies performed in animals or humans with the combination of clotrimazole and betamethasone dipropionate. corticosteroids are generally teratogenic in laboratory animals when administered at relatively low dosage levels. studies in pregnant rats with intravaginal doses up to 100 mg/kg (15 times the maximum

United States - English - NLM (National Library of Medicine)

nucare pharmaceuticals,inc. - clotrimazole (unii: g07gz97h65) (clotrimazole - unii:g07gz97h65), betamethasone dipropionate (unii: 826y60901u) (betamethasone - unii:9842x06q6m) - clotrimazole 10 mg in 1 g - clotrimazole and betamethasone dipropionate cream is a combination of an azole antifungal and corticosteroid and is indicated for the topical treatment of symptomatic inflammatory tinea pedis, tinea cruris, and tinea corporis due to epidermophyton floccosum, trichophyton mentagrophytes, and trichophyton rubrum in patients 17 years and older. none. teratogenic effects pregnancy category c there are no adequate and well-controlled studies with clotrimazole and betamethasone dipropionate cream in pregnant women. therefore, clotrimazole and betamethasone dipropionate cream should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. there have been no teratogenic studies performed in animals or humans with the combination of clotrimazole and betamethasone dipropionate. corticosteroids are generally teratogenic in laboratory animals when administered at relatively low dosage levels. studies in pregnant rats with intravaginal doses up to 100 mg/kg (15 times the maximum

United States - English - NLM (National Library of Medicine)

unit dose services - clotrimazole (unii: g07gz97h65) (clotrimazole - unii:g07gz97h65), betamethasone dipropionate (unii: 826y60901u) (betamethasone - unii:9842x06q6m) - clotrimazole 10 mg in 1 g - clotrimazole and betamethasone dipropionate cream is a combination of an azole antifungal and corticosteroid and is indicated for the topical treatment of symptomatic inflammatory tinea pedis, tinea cruris, and tinea corporis due to epidermophyton floccosum , trichophyton mentagrophytes , and trichophyton rubrum in patients 17 years and older. none. teratogenic effects, pregnancy category c there are no adequate and well-controlled studies with clotrimazole and betamethasone dipropionate cream in pregnant women. therefore, clotrimazole and betamethasone dipropionate cream should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. there have been no teratogenic studies performed in animals or humans with the combination of clotrimazole and betamethasone dipropionate. corticosteroids are generally teratogenic in laboratory animals when administered at relatively low dosage levels. studies in pregnant rats with intravaginal doses up to 100 mg/kg (15 times the maximu

United States - English - NLM (National Library of Medicine)

chain drug marketing association inc. - clotrimazole (unii: g07gz97h65) (clotrimazole - unii:g07gz97h65) - clotrimazole 10 mg in 1 g